Capital Stock Capital Stock

9 Months Ended

Sep. 30, 2013

Equity [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

Capital Stock

On August 20, 2013, the Board of Directors authorized the repurchase up to $250 million in shares with no expiration date. The program's objective is to deploy our capital in a manner that benefits our shareholders and maintains our focus on growth. During the three and nine months ended September 30, 2013, we repurchased 1.0 million shares for $25 million under this program. There are up to $225 million in shares that may still be purchased under this plan.

On August 18, 2012, the Board of Directors authorized the repurchase of up to 2.0 million shares of common stock with no expiration date. The program's objective is to offset dilution associated with various Xylem employee stock plans by acquiring shares in the open market from time to time. There were no shares repurchased under this program during the three months ended September 30, 2013. There were 0.1 million shares repurchased for $2 million under this program during the three months ended September 30, 2012. We repurchased 0.6 million and 0.1 million shares for $17 million and $2 million under this program for the nine months ended September 30, 2013 and 2012, respectively. There are up to 1.0 million shares that may still be purchased under this plan.

Aside from the aforementioned repurchase programs, we repurchased 0.2 million and less than 0.1 million shares for $4 million and less than $1 million during the three months ended September 30, 2013 and 2012, respectively, in relation to settlement of employee tax withholding obligations due as a result of the vesting of restricted stock. Likewise, we repurchased 0.2 million and 0.1 million shares for $6 million and $4 million during the nine months ended September 30, 2013 and 2012, respectively.